Publications dans lesquelles il/elle collabore avec María José Serrano Fernández (17)

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers

    European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 1, pp. 55-62

2016

  1. Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection

    PLoS ONE, Vol. 11, Núm. 2

2014

  1. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497

2013

  1. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407

2012

  1. Biomarkers characterization of circulating tumour cells in breast cancer patients

    Breast Cancer Research, Vol. 14, Núm. 3

2009

  1. Detection of circulating tumor cells in the context of treatment: Prognostic value in breast cancer

    Cancer Biology and Therapy, Vol. 8, Núm. 8, pp. 671-675

2004

  1. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

    Breast Diseases

2003

  1. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

    International Journal of Cancer, Vol. 107, Núm. 6, pp. 984-990

2002

  1. Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines

    Japanese Journal of Cancer Research, Vol. 93, Núm. 5, pp. 559-566

  2. Nk cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis

    Clinical and Diagnostic Laboratory Immunology, Vol. 9, Núm. 6, pp. 1282-1294

  3. Phagocytosis of apoptotic cells assessed by flow cytometry using 7-aminoactinomycin D

    Cytometry, Vol. 49, Núm. 1, pp. 8-11

  4. Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice

    FEMS Immunology and Medical Microbiology, Vol. 33, Núm. 3, pp. 159-163

  5. Use of SYTOX green dye in the flow cytometric analysis of bacterial phagocytosis

    Cytometry, Vol. 48, Núm. 2, pp. 93-96

2001

  1. The use of 7-amino-actinomycin D in the analysis of Candida albicans phagocytosis and opsonization

    Journal of Immunological Methods, Vol. 253, Núm. 1-2, pp. 189-193

2000

  1. Enhanced resistance to experimental systemic candidiasis in tilorone-treated mice

    FEMS Immunology and Medical Microbiology, Vol. 28, Núm. 4, pp. 283-289

1998

  1. c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma

    Invasion and Metastasis, Vol. 18, Núm. 5-6, pp. 261-270